Key | % Net Assets |
---|---|
Vodafone Group PLC | 4.1% |
GlaxoSmithKline PLC | 3.2% |
BT Group PLC | 2.7% |
Legal & General Group PLC | 2.6% |
Other | 87.4% |
Name | % Net Assets |
---|---|
Vodafone Group PLC | 4.1% |
GlaxoSmithKline PLC | 3.2% |
BT Group PLC | 2.7% |
Legal & General Group PLC | 2.6% |
AstraZeneca PLC | 2.5% |
Unilever PLC | 2.5% |
Imperial Tobacco Group PLC | 2.4% |
British American Tobacco PLC | 2.2% |
RSA Insurance Group PLC | 1.9% |
BAE Systems PLC | 1.7% |
No asset data available.
Date | 09-Apr-2021 |
---|---|
Bid | 77.80p |
Offer | 77.80p |
Currency | GBP |
Change | 0.13p |
% | 0.17% |
YTD change | 77.80p |
YTD % | n/a |
Fund Inception | 26/08/1997 |
---|---|
Fund Manager | Chris White |
TER | 1.81 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £2000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.75% |
Annual Mang't | 0.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.07 |
You are here: research